Itzhak Krinsky Joins Halo Pharma Board of Directors
PTSM: Pharmaceutical Technology Sourcing and Management
Krinsky joined the board of directors at Halo after working for Teva Pharmaceuticals for 12 years.
On June 27, 2017, Halo Pharma announced the appointment of Itzhak Krinsky, PhD, to its board of directors. Krinsky has experience in the pharmaceutical industry, investment banking, and an academic career in finance and business economics. Prior to joining Halo, Krinsky worked for Teva Pharmaceuticals for 12 years. He retired from Teva earlier in 2017. During his tenure at Teva, Krinsky served as executive vice-president of Corporate Business Development, a member of the Teva executive committee, chairman of Teva Japan, chairman of Teva South Korea, and head of Business Development Asia Pacific.
Prior to joining Teva, he held various senior positions in investment banks in New York City including with Bankers Trust, Deutsche Bank, and the Silverfern Group, Inc. Krinsky also served as a professor of Finance and Business Economics at the Michael G. DeGroote School of Business, McMaster University, Ontario, Canada. He has published more than 80 articles in peer-reviewed academic journals.
Source: Halo Pharma
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
